[{"id":"1915f7a6-8053-43df-93b9-e85775f2fa36","acronym":"","url":"https://clinicaltrials.gov/study/NCT06765252","created_at":"2025-02-26T07:06:55.090Z","updated_at":"2025-02-26T07:06:55.090Z","phase":"","brief_title":"Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients","source_id_and_acronym":"NCT06765252","lead_sponsor":"Ain Shams University","biomarkers":" CES1","pipe":"","alterations":" ","tags":["CES1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e capecitabine"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 04/01/2024","start_date":" 04/01/2024","primary_txt":" Primary completion: 04/01/2025","primary_completion_date":" 04/01/2025","study_txt":" Completion: 08/01/2025","study_completion_date":" 08/01/2025","last_update_posted":"2025-01-09"}]